These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 33204764)

  • 1. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
    Lofgren SM; Nicol MR; Bangdiwala AS; Pastick KA; Okafor EC; Skipper CP; Pullen MF; Engen NW; Abassi M; Williams DA; Nascene AA; Axelrod ML; Lother SA; MacKenzie LJ; Drobot G; Marten N; Cheng MP; Zarychanski R; Schwartz IS; Silverman M; Chagla Z; Kelly LE; McDonald EG; Lee TC; Hullsiek KH; Boulware DR; Rajasingham R
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa500. PubMed ID: 33204764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19.
    Lofgren SM; Nicol MR; Bangdiwala AS; Pastick KA; Okafor EC; Skipper CP; Pullen MF; Engen NW; Abassi M; Williams DA; Nascene AA; Axelrod ML; Lother SA; MacKenzie LJ; Drobot G; Marten N; Cheng MP; Zarychanshi R; Schwartz IS; Silverman M; Chagla Z; Kelly LE; McDonald EG; Lee TC; Hullsiek KH; Boulware DR; Rajasingham R
    medRxiv; 2020 Sep; ():. PubMed ID: 32743591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
    Rajasingham R; Bangdiwala AS; Nicol MR; Skipper CP; Pastick KA; Axelrod ML; Pullen MF; Nascene AA; Williams DA; Engen NW; Okafor EC; Rini BI; Mayer IA; McDonald EG; Lee TC; Li P; MacKenzie LJ; Balko JM; Dunlop SJ; Hullsiek KH; Boulware DR; Lofgren SM;
    Clin Infect Dis; 2021 Jun; 72(11):e835-e843. PubMed ID: 33068425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Boulware DR; Pullen MF; Bangdiwala AS; Pastick KA; Lofgren SM; Okafor EC; Skipper CP; Nascene AA; Nicol MR; Abassi M; Engen NW; Cheng MP; LaBar D; Lother SA; MacKenzie LJ; Drobot G; Marten N; Zarychanski R; Kelly LE; Schwartz IS; McDonald EG; Rajasingham R; Lee TC; Hullsiek KH
    N Engl J Med; 2020 Aug; 383(6):517-525. PubMed ID: 32492293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
    Rajasingham R; Bangdiwala AS; Nicol MR; Skipper CP; Pastick KA; Axelrod ML; Pullen MF; Nascene AA; Williams DA; Engen NW; Okafor EC; Rini BI; Mayer IA; McDonald EG; Lee TC; Li P; MacKenzie LJ; Balko JM; Dunlop SJ; Hullsiek KH; Boulware DR; Lofgren SM
    medRxiv; 2020 Sep; ():. PubMed ID: 32995820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
    Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
    JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.
    Grau-Pujol B; Camprubí-Ferrer D; Marti-Soler H; Fernández-Pardos M; Carreras-Abad C; Andrés MV; Ferrer E; Muelas-Fernandez M; Jullien S; Barilaro G; Ajanovic S; Vera I; Moreno L; Gonzalez-Redondo E; Cortes-Serra N; Roldán M; Arcos AA; Mur I; Domingo P; Garcia F; Guinovart C; Muñoz J
    Trials; 2021 Nov; 22(1):808. PubMed ID: 34781981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
    Skipper CP; Pastick KA; Engen NW; Bangdiwala AS; Abassi M; Lofgren SM; Williams DA; Okafor EC; Pullen MF; Nicol MR; Nascene AA; Hullsiek KH; Cheng MP; Luke D; Lother SA; MacKenzie LJ; Drobot G; Kelly LE; Schwartz IS; Zarychanski R; McDonald EG; Lee TC; Rajasingham R; Boulware DR
    Ann Intern Med; 2020 Oct; 173(8):623-631. PubMed ID: 32673060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
    Wright JK; Tan DHS; Walmsley SL; Hulme J; O'Connor E; Snider C; Cheng I; Chan AK; Borgundvaag B; McLeod S; Gollob MH; Clarke RJ; Dresser L; Haji F; Mazzulli T; Mubareka S; Jüni P; Lee D; Tomlinson G; Kain KC; Landes M
    Trials; 2020 Jul; 21(1):647. PubMed ID: 32665039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
    Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR
    Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance.
    Rodrigues C; Freitas-Santos RS; Levi JE; Senerchia AA; Lopes ATA; Santos SR; Siciliano RF; Pierrotti LC
    Int J Antimicrob Agents; 2021 Nov; 58(5):106428. PubMed ID: 34454044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.